IAIM
ARCT icon

International Assets Investment Management’s Arcturus Therapeutics ARCT Stock Holding History

International Assets Investment Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,110
Closed -$337K – 493
2021
Q4 		$337K Buy
9,110
+4,350
+91% +$177K 0.06% 322
2021
Q3 		$227K Sell
4,760
-1,325
-22% -$59.4K 0.04% 410
2021
Q2 		$206K Buy
+6,085
New +$206K 0.04% 425

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

International Assets Investment Management's ARCT Position: Q1 2022 in Review

International Assets Investment Management sold out of Arcturus Therapeutics (ARCT) in Q1 2022, closing a stake of 9,110 shares — an estimated $337K sold.

International Assets Investment Management first reported a position in ARCT in Q2 2021 and held it in 3 quarters. The position peaked at $337K in Q4 2021. 130 funds tracked by Wall St. Rank hold ARCT as of Q1 2022.

  • International Assets Investment Management reported no remaining Arcturus Therapeutics position as of Q1 2022 after selling out during the quarter.
  • International Assets Investment Management sold 9,110 Arcturus Therapeutics shares in Q1 2022, an estimated $337K.
  • International Assets Investment Management first reported a position in Arcturus Therapeutics in Q2 2021 and held it in 3 quarters.
  • International Assets Investment Management's Arcturus Therapeutics position peaked at $337K in Q4 2021.
  • 130 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2022.

Based on International Assets Investment Management's 13F filing for Q1 2022, filed 3 May 2022.